First FDA-approved laboratory test for quantifying DNA of potentially deadly virus helps physicians manage organ transplant patients on antiviral therapy "With this new test, diagnostic laboratories ...

Please provide your email address to receive an email when new articles are posted on . The FDA granted marketing authorization to Meridian Bioscience Inc. for the Alethia CMV Assay Test System to aid ...

KANSAS CITY, Mo.--(BUSINESS WIRE)--ViraCor Laboratories, the leader in molecular diagnostic testing for infectious diseases, today announced the launch of a new cytomegalovirus (CMV) antiviral ...

Cytomegalovirus (CMV) is an important cause of morbidity and mortality in transplant patients, and is typically monitored using laboratory-developed quantitative molecular assays. Clinicians who use ...

PITTSBURGH--(BUSINESS WIRE)--Plexision, a biotechnology company, is offering the first blood test panel capable of reporting the risk of cytomegalovirus infection and transplant rejection within six ...

Please provide your email address to receive an email when new articles are posted on . University CMV testing among newborns is not common. In Minnesota, the first state with universal CMV testing, a ...

Congenital CMV is the most frequent infectious cause of neonatal malformation in developed nations. Yet, this disease is largely under-recognized by health authorities and the general public. There is ...

Credit: Getty Images This review provides a concise overview of the epidemiology, etiology, history, diagnostic criteria, and management of CMV infection in solid organ transplant recipients.

Cytomegalovirus (CMV) is one of the most common human herpesviruses, infecting nearly half of the adult population in the US. Vertical transmission can occur during pregnancy, and congenital CMV ...

A 21-year-old man was evaluated as a stem cell donor for his fully HLA-matched brother. A week earlier, he reported the onset of a low-grade fever and a sore throat that resolved without medical care.